People | June 17, 2022
GlycoEra AG appoints Tanmoy Ganguly as Chief Scientific Officer
Ganguly will execute company's strategic focus on leveraging CustomGlycan to develop novel therapeutics
Ganguly will execute company's strategic focus on leveraging CustomGlycan to develop novel therapeutics
We see significant potential in working with oncolytic virus companies and Neo antigen-companies
TMA will leverage Syntegra's synthetic data engine to accelerate the building of predictive diagnostic algorithms
Large datasets will train machine learning models and speed up agile discovery of novel crop protection solutions
48% of people are either hypertensive or at risk of becoming hypertensive & 30% of people have a high Waist Hip Ratio (WHR) – an early indication of the onset of CVDs
EPR-Technologies is pursuing development of an unprecedented standard of emergency care when CPR fails
The innovative software module is designed to meet growing scientific demand from researchers and drug developers
This new formulation represents a significant improvement over protease inhibitor-containing paediatric ARV formulations that have been used in South Africa for decades.
Redbiotec has a right to royalties on Eurocine Vaccines´ net sales of an approved HSV-2 vaccine, should such sales arise.
Becomes the first airline globally to develop and launch sustainable, temperature-controlled containers for the transportation of pharmaceuticals
Subscribe To Our Newsletter & Stay Updated
